Idorsia today

Idorsia began its operations after the demerger from Actelion on June 15, 2017, and registered shares of Idorsia Ltd were listed on the SIX Swiss Exchange the following day. Today, Idorsia has an experienced team of highly qualified professionals, a full R&D pipeline, state of-the-art facilities, and a healthy balance sheet – the ideal constellation for bringing successful medicines to the market. 
Idorsia is so much more than a start-up!